261 related articles for article (PubMed ID: 29290626)
1. TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2
Li R; Zhou Y; Cao Z; Liu L; Wang J; Chen Z; Xing W; Chen S; Bai J; Yuan W; Cheng T; Xu M; Yang FC; Zhao Z
Stem Cell Reports; 2018 Jan; 10(1):166-179. PubMed ID: 29290626
[TBL] [Abstract][Full Text] [Related]
2. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
[TBL] [Abstract][Full Text] [Related]
3. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis.
Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K
Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061
[TBL] [Abstract][Full Text] [Related]
4. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
[TBL] [Abstract][Full Text] [Related]
5. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells.
Pan F; Wingo TS; Zhao Z; Gao R; Makishima H; Qu G; Lin L; Yu M; Ortega JR; Wang J; Nazha A; Chen L; Yao B; Liu C; Chen S; Weeks O; Ni H; Phillips BL; Huang S; Wang J; He C; Li GM; Radivoyevitch T; Aifantis I; Maciejewski JP; Yang FC; Jin P; Xu M
Nat Commun; 2017 Apr; 8():15102. PubMed ID: 28440315
[TBL] [Abstract][Full Text] [Related]
6. Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.
Cakouros D; Hemming S; Gronthos K; Liu R; Zannettino A; Shi S; Gronthos S
Epigenetics Chromatin; 2019 Jan; 12(1):3. PubMed ID: 30606231
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-199a-5p in osteoblast differentiation by targeting TET2.
Qi XB; Jia B; Wang W; Xu GH; Guo JC; Li X; Liu JN
Gene; 2020 Feb; 726():144193. PubMed ID: 31669647
[TBL] [Abstract][Full Text] [Related]
8. [Functional analysis of TET2 using a knockdown mouse model].
Shide K; Kameda T; Shimoda K
Rinsho Ketsueki; 2015 Jun; 56(6):657-65. PubMed ID: 26256876
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.
Sun J; He X; Zhu Y; Ding Z; Dong H; Feng Y; Du J; Wang H; Wu X; Zhang L; Yu X; Lin A; McDonald T; Zhao D; Wu H; Hua WK; Zhang B; Feng L; Tohyama K; Bhatia R; Oberdoerffer P; Chung YJ; Aplan PD; Boultwood J; Pellagatti A; Khaled S; Kortylewski M; Pichiorri F; Kuo YH; Carlesso N; Marcucci G; Jin H; Li L
Cell Stem Cell; 2018 Sep; 23(3):355-369.e9. PubMed ID: 30146412
[TBL] [Abstract][Full Text] [Related]
10. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.
Cheng J; Guo S; Chen S; Mastriano SJ; Liu C; D'Alessio AC; Hysolli E; Guo Y; Yao H; Megyola CM; Li D; Liu J; Pan W; Roden CA; Zhou XL; Heydari K; Chen J; Park IH; Ding Y; Zhang Y; Lu J
Cell Rep; 2013 Oct; 5(2):471-81. PubMed ID: 24120864
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells.
Jin X; Qin T; Zhao M; Bailey N; Liu L; Yang K; Ng V; Higashimoto T; Coolon R; Ney G; Figueroa ME; Li Q
Blood Adv; 2018 Jun; 2(11):1259-1271. PubMed ID: 29866713
[TBL] [Abstract][Full Text] [Related]
12.
Kunimoto H; McKenney AS; Meydan C; Shank K; Nazir A; Rapaport F; Durham B; Garrett-Bakelman FE; Pronier E; Shih AH; Melnick A; Chaudhuri J; Levine RL
Blood; 2017 Mar; 129(13):1779-1790. PubMed ID: 28077417
[TBL] [Abstract][Full Text] [Related]
13. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
Song SJ; Ito K; Ala U; Kats L; Webster K; Sun SM; Jongen-Lavrencic M; Manova-Todorova K; Teruya-Feldstein J; Avigan DE; Delwel R; Pandolfi PP
Cell Stem Cell; 2013 Jul; 13(1):87-101. PubMed ID: 23827711
[TBL] [Abstract][Full Text] [Related]
15. The Positive Effect of TET2 on the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells.
Feng L; Zhou J; Xia B; Tian BF
Cell Reprogram; 2020 Feb; 22(1):3-13. PubMed ID: 31829736
[TBL] [Abstract][Full Text] [Related]
16. Wnt7b-induced Sox11 functions enhance self-renewal and osteogenic commitment of bone marrow mesenchymal stem cells.
Yu F; Wu F; Li F; Liao X; Wang Y; Li X; Wang C; Shi Y; Ye L
Stem Cells; 2020 Aug; 38(8):1020-1033. PubMed ID: 32346881
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis.
Cai Z; Kotzin JJ; Ramdas B; Chen S; Nelanuthala S; Palam LR; Pandey R; Mali RS; Liu Y; Kelley MR; Sandusky G; Mohseni M; Williams A; Henao-Mejia J; Kapur R
Cell Stem Cell; 2018 Dec; 23(6):833-849.e5. PubMed ID: 30526882
[TBL] [Abstract][Full Text] [Related]
18. [Tet2 regulates the function of mesenchymal stem cells].
Gu J; Wang Y; Gao J; Yuan S; Chu Y; Li Y; Yuan W; Wang X
Sheng Wu Gong Cheng Xue Bao; 2019 Jan; 35(1):142-149. PubMed ID: 30756543
[TBL] [Abstract][Full Text] [Related]
19. The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells.
Zhao Z; Chen S; Zhu X; Pan F; Li R; Zhou Y; Yuan W; Ni H; Yang FC; Xu M
Leukemia; 2016 Aug; 30(8):1784-1788. PubMed ID: 27003514
[No Abstract] [Full Text] [Related]
20. Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter.
Yang R; Yu T; Kou X; Gao X; Chen C; Liu D; Zhou Y; Shi S
Nat Commun; 2018 Jun; 9(1):2143. PubMed ID: 29858571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]